Midcap stocks that outperformed in 2013

NDTV Profit Desk

06 Jan 2014, 10:46 AM IST

Blue chip stocks drove Indian equity markets in 2013, but small and mid-cap stocks returned huge losses of up to 16 per cent. The BSE's mid-cap and small-cap indices fell by about 10 per cent and 16 per cent, respectively, in 2013.

Last year, mid and small cap stocks gave returns of up to 40 per cent. They outperformed the Sensex, which rose about 25 per cent during 2012. However, there have been some pockets of strength even in the broader markets.

Here are nine midcap stocks that are trading around their 52-week highs and have outperformed the broader markets.

1) Just Dial: The company had a stellar listing in June 2013. The stock hit a high of Rs. 1,603.5 apiece on January 3 after debuting at Rs 611.45. The stock's all-time high is at Rs 1,648. Founded by V S S Mani, the company started offering local search services in 1996 under the Just Dial brand.

2) Divi's Labs: It is engaged in manufacture of generic APIs (Active Pharmaceutical Ingredients) and intermediates for innovator companies and other specialty chemicals like peptides and nutraceuticals. The stock is trading near its 52-week high of Rs 1,258.70.

3) Havells India: The electrical goods maker has reported strong numbers and is trading at year-high of Rs 827.

4) Biocon: The biotechnology company recently entered into an agreement with Quark Pharmaceuticals for development of a new range of therapeutics. The stock is trading near its 52-week high of 490.

5) Mindtree: IT stocks had a fabulous 2013 and Mindtree is no exception. The stock more than doubled through last year and is now trading near its 52-week high of Rs 1,622.

6) TVS Motor: The two-wheeler maker outperformed despite sluggish auto sales. The stock is trading near 52-week high of Rs 82.35.

7) Ceat: The tyre maker has done phenomenally well after financials improved due to softening of the raw material costs and enhanced demand. It is trading near its 52-week high of Rs 366.

8) JB Chemicals & Pharmaceuticals: The drugmaker manufactures & markets a diverse range of pharmaceutical formulations, herbal remedies and APIs. The company's US business has shown good growth in the last two years. The stock is trading near 52-week high of Rs 138.90.